Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	129.00	99.71	43.54
Graham Fair Price	-51.24	24.73	50.71
PEG	79.22	-0.74	-3.57
Price/Book	106.57	10.78	5.22
Price/Cash Flow	132.05	155.93	67.20
Prices/Earnings	135.84	40.59	17.21
Price/Sales	118.74	32.51	14.86
Price/FCF	132.05	155.93	67.20
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-17.51	0.33	0.40
Operating Margin	-5.98	0.26	0.28
ROA	-11.68	0.05	0.06
ROE	0.08	0.07	-12.41
ROIC	0.07	0.06	-12.60
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.60	1.51	-60.09
Dividends QOQ	< 0.005	-0.35	-5825.95
EBIT QOQ	-0.05	-0.08	-52.27
EPS QOQ	-0.05	-0.55	-1034.73
FCF QOQ	0.29	-0.08	-72.09
Revenue QOQ	-0.01	-0.02	-82.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1.80	-63.06	-3396.23
Days Sales Outstanding (DSO)	37.03	37.20	0.47
Inventory Turnover	-49.90	-1.43	97.14
Debt/Capitalization	0.02	0.02	-18.71
Quick Ratio	1.93	2.15	11.67
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.83	20.23	-47.90
Cash	3.96	2.67	-32.50
Capex	-0.97	-0.55	43.15
Free Cash Flow	3.02	1.40	-53.62
Revenue	13.64	6.71	-50.80
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.10	2.29	9.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.46	-1.06	-130.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating